Gaudium IVF & Women Health Limited
NSE: GAUDIUMBSE: GAUDIUM
MAINBOARD
OPEN
Grey Market Premium*
UPDATED: 20-Feb-2026 19:59₹8+10.13%
Est. Listing*₹87
Upper band ₹79
* GMP indicative only. Not investment advice.
Subscription Status
| Category | Offered | Bids | Times (x) |
|---|---|---|---|
| QIB | 41,77,240 | 2,646 | 0.00x |
| HNI | 31,32,930 | 28,51,821 | 0.91x |
| Retail | 73,10,170 | 1,04,23,161 | 1.43x |
| Total | 1,46,20,340 | 1,32,77,628 | 0.91x |
Financial Performance
Figures in ₹ Crores unless specified
| Metric | Sep-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| Assets | 106.62 | 88.51 | 51.01 | 36.63 |
| Total Income | 49.75 | 70.96 | 48.15 | 44.26 |
| PAT | 12.51 | 19.13 | 10.32 | 13.53 |
| EBITDA | 18.95 | 28.63 | 19.27 | 20.07 |
| Net Worth | 58.85 | 46.3 | 26.99 | 22.73 |
| Reserves | 28.16 | 15.6 | 26 | 21.74 |
| Total Borrowing | 22.51 | 18.93 | 15.73 | 9.78 |
Key Performance Indicators
| KPI | Sep-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| RoNW (%) | - | - | - | - |
| EPS (₹) | 2.04 | 3.12 | 1.68 | 2.2 |
| P/E (Pre) | 25.36 | - | - | - |
| P/E (Post) | 22.99 | - | - | - |
IPO Details
Price Band
₹75 - ₹79189 Shares
Lot Size
189 Shares
Total Issue Size
₹165 Cr2,08,86,200 Shares
Fresh Issue
₹90 Cr1,13,92,500 Shares
Offer for Sale
₹75 Cr94,93,700 Shares
Face Value
₹5
Listing At
NSE, BSE
Dates
IPO Open
20 Feb 2026
IPO Close
24 Feb 2026
Allotment
25 Feb 2026
Listing
27 Feb 2026
IPO Open20 Feb 2026
IPO Close24 Feb 2026
Allotment25 Feb 2026
Listing27 Feb 2026
Lot Size & Investment Limits
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail | 1 | 189 | 14931 |
| sHNI | 14 | 2646 | 209034 |
| bHNI | 67 | 12663 | 1000377 |
Peer Comparison
| Company | CMP (₹) | P/E Ratio | ROE (%) |
|---|---|---|---|
| Progyny Inc | 2,099.98 | 41.56 | 12.9% |
| Inspire IVF Public Company Limited | 1.99 | 11.43 | 3.97% |
About Gaudium IVF & Women Health Limited
Gaudium IVF & Women Health Limited provides IVF and women healthcare services across India through a hub-and-spoke model.
Company Information
Registered Address
B1/51, Janak Puri, B-1, New Delhi 110058
Lead Managers
- Sarthi Capital Advisors Private Limited
Company Strengths
- ✓Patient-centric pricing approach
- ✓Strong brand positioning and trust
- ✓Focus on medical tourism
Key Risks
- ⚠Operational and medical risks
- ⚠Related party transaction risks
- ⚠Dependence on limited embryologists
Objects of the Issue
• Expansion of IVF centres
• Investment in medical technology
• Working capital requirements
• General corporate purposes
Grey Market Premium*
UPDATED: 20-Feb-2026 19:59₹8+10.13%
Est. Listing*₹87
Upper band ₹79
* GMP indicative only. Not investment advice.
Subscription Status
| Category | Offered | Bids | Times (x) |
|---|---|---|---|
| QIB | 41,77,240 | 2,646 | 0.00x |
| HNI | 31,32,930 | 28,51,821 | 0.91x |
| Retail | 73,10,170 | 1,04,23,161 | 1.43x |
| Total | 1,46,20,340 | 1,32,77,628 | 0.91x |
Registrar Contact
Bigshare Services Pvt Ltd
Waiting for Allotment
Disclaimer
Investment in Pre-IPO/Unlisted Shares/IPO is subject to market risks. OpenIPO.in is not a SEBI registered entity. The information provided here is for educational purposes only and should not be considered as financial advice. GMP prices are estimated based on market rumors and may vary. Please consult your financial advisor before making any investment decisions.